COOCooper Companies (The)

$72.67

$58.9852 weeks$84.32

Price

$72.67+6.7%1Y

1M+3.4%1Y+6.7%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

6/10

Value41

Quality79

Momentum52

Growth48

Strongest Quality, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

The Cooper Companies, Inc. (Cooper, we or the Company), is a leading global medical device company focused on helping people experience life's beautiful moments. Headquartered in San Ramon, California, Cooper sells products in over 130 countries and positively impacts over fifty million lives each year. Cooper operates through two business segments, CooperVision and CooperSurgical. Our two business segments elevate standards of care with products and services in the fields of vision, fertility and women’s health.

In the company’s own words · 10-K filed Dec 5, 2025 · SEC EDGAR

P/E (TTM)62.1

Market Cap$12.85B

1Y Return+6.7%

5Y Return-31%

Business segments

Q2 2026 · $1.08B

The company’s own SEC segment disclosure.

Toric And Multifocal$364.9M34%
Sphere Other$358.6M33%
Office And Surgical$214.2M20%
Fertility$143.8M13%

Cooper Companies (The) (COO) reported revenue of $1.08B in Q2 2026 (quarter ended April 30, 2026), up 7.9% from the same quarter a year earlier. That came with a gross margin of 68% and net loss of $78M. For the full year FY2025, revenue was $4.09B (+5.1% year on year) and net income $375M. Its largest product in 2026-Q2 was Toric And Multifocal at $365M, 34% of the disclosed total, just ahead of Sphere Other at 33%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Medical Instruments & Supplies

Ranks #19 of 27 by Smart Score

West Pharmaceutical Services